http://www.publicwire.com NEW YORK, March 11, 2014 /PRNewswire via COMTEX/ ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) today announced that it had entered into an exclusive license agreement with HANMI PHARMACEUTICAL CO., LTD. (KSE: 128940) related to MuGard commercialization in South Korea. Under the terms of the license agreement, Access will receive an upfront licensing fee and double [...]
http://www.publicwire.com/2014/03/11/accp-access-pharmaceuticals-announces-mugard-license-agreement-with-hanmi-pharmaceutical-in-korea/
No comments:
Post a Comment